Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial.
about
Advances in understanding and managing atopic dermatitisImmune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted TherapeuticsConsensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment.Hand dermatitis: an allergist's nightmare.Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?Anti-inflammatory therapies in atopic dermatitis.Addressing treatment challenges in atopic dermatitis with novel topical therapies.The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update.Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook.Topical E6005/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis.The Future of Atopic Dermatitis Treatment.New therapies for controlling atopic itch.2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis.Hematocrit-independent recovery is a key for bioanalysis using volumetric absorptive microsampling devices, Mitra™.Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
P2860
Q26766224-C64E67FE-7DA5-419D-8DE6-721AF62ABE63Q26799532-2EC4ECDF-F212-418A-90FC-A77679662AA1Q36214247-05B998BD-58A5-4FA7-85AA-C9EA34508913Q38250259-BE7193C2-D1EC-44C6-B9BC-49F20EEAC8EEQ38452688-D402790D-16F8-481A-9D93-0E7C2A465C6CQ38812100-08046D46-7CAE-46F8-859D-3F1A8A8C2FE7Q38831401-D94E71C4-A8AD-4628-BDF3-11C8B37ED2FEQ38879975-C48EAAF1-2369-4378-A4F7-C27519AF8640Q38883893-5B99C762-B89C-4310-9A8E-BB10B244E0E1Q39417376-15727B6E-2BB6-4860-9E38-A4D32DD3FDD4Q47877796-C128DE42-C013-4E6E-8F5C-9B0AD8B9315CQ47880524-C6E481D3-F608-4186-8C1F-0A1A6408B3D0Q47941158-D7C4A29B-BDF7-42CF-BF3A-2238A7EF3344Q51099897-400C9141-F5B9-43CA-B0DC-F28989741F98Q51799778-F92AF8D9-037C-4509-AFFA-E4FCB5304540Q58606499-D387C52D-65D0-4C12-88E4-36806D845244
P2860
Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Safety and efficacy of topical ...... d, multicenter clinical trial.
@en
Safety and efficacy of topical ...... d, multicenter clinical trial.
@nl
type
label
Safety and efficacy of topical ...... d, multicenter clinical trial.
@en
Safety and efficacy of topical ...... d, multicenter clinical trial.
@nl
prefLabel
Safety and efficacy of topical ...... d, multicenter clinical trial.
@en
Safety and efficacy of topical ...... d, multicenter clinical trial.
@nl
P2093
P2860
P356
P1476
Safety and efficacy of topical ...... d, multicenter clinical trial.
@en
P2093
Hidemi Nakagawa
Hideto Akama
JAPANESE E6005 Study Investigators
Masutaka Furue
Nobukazu Hayashi
Seiichiro Hojo
Yasumi Kitahara
P2860
P304
P356
10.1111/1346-8138.12534
P577
2014-06-18T00:00:00Z